Market Overview - The Hang Seng Index rose by 0.9% last week, closing at 24,139 points, while the Hang Seng Tech Index increased by 0.6% to 5,248 points[1] - Weekly market turnover decreased by 1.7% to HKD 242.5 billion, with a net inflow of HKD 20.7 billion through the Stock Connect[1] - The market is experiencing significant rotation among sectors, with strong inflows into stablecoin concept stocks, brokerages, and biopharmaceuticals, indicating a positive investment cycle[1] Macroeconomic Insights - The latest FOMC minutes revealed that only a few Fed officials support a rate cut in July, with most concerned about inflation risks from new tariffs[2] - Initial jobless claims in the U.S. unexpectedly fell to 227,000, the lowest in seven weeks, indicating a resilient labor market[2] Sector Performance - The consumer sector saw declines, with stocks like Maogeping and Lao Pu Gold dropping between 5% and 9% last week[3] - The vocational education sector performed well, with New Higher Education and China Spring rising by 24.2% and 14.6%, respectively[3] Healthcare Sector - The Hang Seng Healthcare Index slightly declined by 0.05% after two weeks of gains, despite WuXi AppTec's stock surging by 10.5% following a positive earnings announcement[4] - WuXi AppTec expects a revenue of approximately RMB 20.8 billion for H1 2025, reflecting a year-on-year growth of about 20.6%[4] Energy and Utilities - The renewable energy and utilities sectors experienced slight fluctuations, with notable increases in stocks like Xinyi Solar and GCL-Poly Energy, rising by 2.4% and 9.8%, respectively[5] - Environmental stocks also saw gains, with Everbright Environment and Beijing Enterprises Water rising by 3.8% and 5.7%[5] Company-Specific Updates - Tianlun Gas is expected to return to profit growth starting FY25, with a projected CAGR of 12.0% for net profit from FY24 to FY27[6] - The company aims to increase its dividend payout ratio from 30.0% in FY23 to 35.0% by FY25, indicating a commitment to shareholder returns[11]

发展新质生产力是上海乃至整个中国经济迈向高质量发展的必由之路。其根本在于从要素驱动向创 新驱动的转变。上海需要把握"十五五"期间的发展机遇，通过发展新质生产力，为上海的经济转型和持 续增长提供强大的内生动力。 从要素驱动到创新驱动 从理论层面理解上海发展新质生产力的意义。一方面，从要素驱动到创新驱动的转变是现代经济发 展的必然趋势。传统的经济增长模式主要依赖于资本、劳动力和资源等要素的投入，然而随着要素成本 的上升以及资源环境压力的增大，这种模式的可持续性逐渐减弱。因此，转向以科技创新、知识资本和 高附加值产业为核心的创新驱动发展模式，成为经济增长的新方向。在这一转型过程中，新质生产力， 即由新技术、新产业、新模式所推动的生产力，成为关键动力源。新质生产力不仅能够打破要素驱动的 增长瓶颈，还能通过技术进步和创新引领，实现经济增长方式的根本性转变。 另一方面，新质生产力在上海经济结构优化升级中的作用至关重要。上海作为中国经济的龙头城 市，正处于从传统制造业主导向现代服务业、高新技术产业和创新经济转型的关键时期。在这一转型过 程中，新质生产力通过推动传统产业的数字化、智能化改造，大幅提升了生产效率和产品附加值。例 ...

Core Viewpoint - The establishment of national-level economic and technological development zones is a significant measure for advancing reform and opening up in China, contributing to high-quality development and deepening reforms through high-level openness [1][2]. Group 1: Importance of National-Level Economic and Technological Development Zones - National-level economic and technological development zones are crucial for economic development and serve as important windows for foreign trade and investment, especially in the context of increasing global protectionism and unilateralism [2]. - Over 40 years, these zones have expanded from coastal cities to 232 zones across 31 provinces, with over 60,000 foreign-funded enterprises and approximately 99,000 foreign trade enterprises, accounting for about one-quarter of the national actual foreign investment and import-export volume in 2024 [3]. Group 2: Policy Measures and Development Strategies - The "Work Plan for Deepening Reform and Innovation of National-Level Economic and Technological Development Zones" outlines 16 policy measures across four areas: developing new productive forces, enhancing the level of open economy, deepening management system reforms, and strengthening factor guarantees [3][4]. - The plan supports the establishment of major industrial technology innovation platforms in qualified zones and encourages participation in high-quality Belt and Road initiatives [4]. Group 3: Role of Foreign Enterprises - Foreign enterprises, such as Panasonic, play a vital role in the development of national-level economic and technological development zones, benefiting from favorable business environments and policy support [5][10]. - Panasonic's sales revenue in China for the 2024 fiscal year is nearly 100 billion RMB, representing 24.4% of its global business, highlighting the significance of the Chinese market for foreign companies [5]. Group 4: Technological and Industrial Innovation - National-level economic and technological development zones are home to over 700 national incubators and innovation spaces, with high-tech enterprises accounting for 18.3% of the national total [7]. - The zones are focusing on integrating technological and industrial innovation, with policies aimed at enhancing innovation capabilities and solidifying the foundation for high-quality manufacturing [8]. Group 5: Future Development and Global Integration - The zones are encouraged to explore new paths for autonomous opening up and to create replicable and promotable institutional innovation results, contributing to the modernization of China [13]. - The plan emphasizes the need for a modern industrial system led by strategic emerging industries such as biomedicine, new energy materials, aerospace, and artificial intelligence [9].

Group 1 - The Shanghai Stock Exchange has officially released the "1+6" policy framework for the Sci-Tech Innovation Board reform, which includes three business guidelines and two revised business guidelines aimed at enhancing the inclusiveness and adaptability of the system [1][2] - The "Sci-Tech Growth Layer Guidelines" specify the requirements for technology companies that have not yet turned a profit at the time of listing, allowing both existing and newly registered unprofitable companies to enter this layer without additional listing thresholds [2] - The current 32 unprofitable companies on the Sci-Tech Innovation Board will automatically enter the Sci-Tech Growth Layer upon the implementation of the guidelines, with a full coverage in the Sci-Tech Composite Index [2] Group 2 - The Huaxia Sci-Tech Composite Index ETF (589000) has seen a recent increase of 1.24% over the past week, with a trading volume of 76.28 million yuan and a turnover rate of 4.23% [1] - The Huaxia Sci-Tech 100 ETF (588800) focuses on high-potential stocks in the electronic, pharmaceutical, and new energy sectors, which are currently experiencing a recovery in market conditions [3] - The introduction of the Sci-Tech Growth Layer and the resumption of the fifth set of listing standards for unprofitable companies are expected to provide significant opportunities for investors in cutting-edge fields such as artificial intelligence and commercial aerospace [2]

Group 1: Hong Kong IPO Market Overview - In the first half of 2025, Hong Kong's IPO market showed strong performance with 44 IPOs completed, an increase of 14 from the same period last year, raising over 105 billion HKD [2] - June 2025 marked a peak in IPO activity with 15 companies listed, reflecting a market trend towards "hard technology + new consumption" [3] - The total net fundraising from the 15 companies in June was approximately 73.87 billion HKD, with significant contributions from Sanhua Intelligent (24.74 billion HKD) and Haitian Flavoring (20.07 billion HKD) [4] Group 2: Companies Listed in June - Notable companies that went public in June include MetaLight Inc. (data intelligence), Haitian Flavoring (seasoning), and Cloud Travel (transportation platform), with share prices ranging from 2.86 HKD to 205 HKD [4] - The IPOs were characterized by a concentration of fundraising among leading companies, indicating a trend where consumer and technology manufacturing sectors drive the market [4] Group 3: Upcoming and Recent Listings - From June 23 to June 29, three companies passed the listing hearing, including Weili Zhibo (biopharmaceuticals), Dazhong Dental (dental services), and Shougang Langze (carbon technology) [5][6] - In June, 77 companies submitted applications to list on the Hong Kong main board, covering sectors such as biomedicine, semiconductors, and smart vehicles, indicating a robust interest in capital markets [7] Group 4: US IPO Market Overview - By June 2025, 45 Chinese companies completed listings in the US, with a notable focus on Nasdaq as the primary listing venue [10] - In June, six Chinese companies listed in the US, with four using traditional IPO methods and two utilizing SPACs, showcasing a diverse range of industries including biotechnology and consumer services [11][12] Group 5: Fundraising Trends - The fundraising landscape for Chinese companies in the US showed a split between SPAC-driven headliners and traditional IPOs, with many projects reflecting cautious market sentiment regarding valuations and risks [15] - The overall trend indicates an improvement in quality and structure of listings, with healthcare, technology, and consumer sectors being the focal points for capital investment [18]

Core Viewpoint - Hainan aims to accelerate the construction of a modern industrial system by leveraging its resource endowments, policy frameworks, and geographical advantages [1] Group 1: Industry Development - Hainan will vigorously promote the enhancement and optimization of four leading industries [1] - The focus will be on building an international tourism consumption center while maintaining a dual-driven approach of productive and life service industries [1] - The province plans to cultivate and expand high-tech industry clusters in offshore wind power, biomedicine, petrochemical new materials, and integrated circuits [1] Group 2: Agricultural and Technological Innovation - Hainan seeks to enhance the stable production and supply capacity of natural rubber [1] - The establishment of a national tropical agricultural science center and the dual high ground of agricultural technology innovation and open cooperation is a priority [1] - There will be a deep integration of technological innovation and industrial innovation, focusing on new fields such as seed industry, deep sea, commercial aerospace, green low-carbon, and biomanufacturing [1]

Core Insights - Temasek's investment portfolio net worth reached SGD 434 billion for FY2025, marking an increase of SGD 45 billion from the previous fiscal year, achieving a historical high [1] - The one-year shareholder return rate for Temasek was 11.8%, with 20-year and 10-year annualized returns at 7% and 5% respectively [1] Investment Strategy - Temasek has maintained a long-term investment philosophy, focusing on resilient assets with good cash flow that can withstand market cycles [2] - The company has consistently overweighted Chinese assets, with a slight decrease in the proportion of Chinese assets in the portfolio from 19% to 18%, but the net value of these assets increased by over SGD 4 billion [2][3] Market Outlook - Temasek emphasizes the importance of long-term investment returns over short-term performance, especially in a complex market environment [2] - The company believes that the global trend of globalization will not reverse, and that trade protectionism reflects economic imbalances that need to be addressed [4] Chinese Market Focus - Temasek's investment focus in China includes sectors such as TMT (Technology, Media, and Telecommunications), life sciences, advanced manufacturing, and new consumption [3][5] - The company recognizes the significant shift in Chinese companies' competitive advantages, moving from labor to engineering and now to research and development [3] Consumer Brand Development - Temasek views the rise of new Chinese consumer brands as a significant trend, noting that Chinese products are entering a new era of brand premium [5] - The emotional value of brands is highlighted, with examples of Chinese brands gaining international recognition and establishing a strong market presence [5] Policy Impact on Consumption - Recent macroeconomic policies in China have positively influenced consumer confidence and spending, with direct and indirect effects on consumption [6] - The company notes that a robust capital market and a high-quality development framework are essential for sustaining consumer growth [6] Valuation Perspective - Current valuations of Chinese assets are considered reasonable, with potential for further recovery as corporate fundamentals improve [7] - Temasek continues to invest in early-stage companies, particularly in China, while focusing on quality projects rather than broad diversification [8] Investment Vehicle Development - Temasek established a dedicated team for early-stage investments and launched a private equity fund,淡明资本, to focus on early investments in life sciences in China [8][9] - The fund aims to expand its currency base from USD to RMB, maintaining a strategy aligned with Temasek's investment philosophy [9]

Group 1 - The market showed positive performance last week, with the China Securities Xinhua National Brand Index rising by 1.78% to 1679.33 points [1] - Key stocks such as Sungrow Power, Tigermed, and Kangtai Biological performed strongly, with Sungrow Power leading with a 12.50% increase [1] - Year-to-date, notable performers include Xinlitai with a 47.42% increase, WuXi AppTec with a 43.21% rise, and Anji Technology up by 38.52% [2] Group 2 - The market sentiment is shifting towards a bullish outlook, with institutions optimistic about future performance due to a lack of systemic risks and positive reactions to favorable information [2] - Key sectors of interest include computing power chains, new consumption, and innovative pharmaceuticals, with high-dividend assets expected to attract institutional investment [2] - The ongoing revaluation of Chinese assets is supported by continuous breakthroughs in domestic technology innovation and favorable policies, which are expected to enhance supply-demand dynamics in the domestic market [3]

Core Viewpoint - The introduction of the "1+6" policy and supporting business rules for the Sci-Tech Innovation Board (STAR Market) is facilitating the acceleration of core technology breakthroughs and industrialization processes for many unprofitable listed companies [1][2][3]. Group 1: Impact on Companies - Companies like Zejing Pharmaceutical have successfully launched multiple innovative drugs since their listing, benefiting from the supportive policies aimed at hard-tech enterprises [1]. - Aibi Zhongguang, which went public in an unprofitable state, anticipates turning profitable by Q1 2025, attributing its growth to the increasingly accommodating financing environment of the capital market [1]. - Tuojing Technology, focusing on high-end semiconductor equipment, achieved profitability in its first year post-listing, demonstrating the positive impact of the STAR Market platform [1]. Group 2: Policy Benefits - The establishment of the Sci-Tech Growth Layer and the resumption of the fifth listing standard are seen as measures that cater to the needs of technology innovation enterprises, allowing for a more patient capital approach towards companies with key technologies and clear growth paths [2][3]. - The reforms are expected to reshape valuation logic, emphasizing long-term value indicators such as technological maturity and market development potential, particularly for hard-tech sectors like semiconductors and biomedicine [2]. - The policies are designed to alleviate financing pain points for tech companies, enabling a more rational assessment of technological accumulation and long-term potential rather than focusing solely on short-term profitability [3].

A股市场总市值突破百万亿元、常态化稳市机制不断健全、服务实体经济效能明显提升、对外开放大门 越敞越大……今年以来，资本市场全面深化改革步伐加快，对内改革与对外开放并重，政策红利激发出 的市场活力，正逐步传导至资本市场每个角落，各路资金争相投下信任票。 科技变革的脚步催促声渐急，以改革之力厚植科创沃土成为必然。年初以来，全球经济格局重塑，贸易 摩擦频发，以DeepSeek为代表的技术突破，论证了持续加快推进改革创新的必要性，"科技创新"成为了 中国经济高质量发展的"题眼"与资本市场深化改革的题中应有之义。如何畅通金融资本与科创要素的通 道，怎样走出支持科技创新和产业创新融合发展的"中国路径"，成为摆在资本市场面前的必答题。 深化制度改革成为支持科技创新的题中之义。今年以来，持续优化股债融资的一系列服务实体经济 的"实招"出台落地，以深化科创板"1+6"改革、"并购六条"等为代表的政策制度相继推出，着力打造更 具吸引力、竞争力的市场体系和产品服务矩阵，支持全面创新的资本市场生态正在加速构建。 "考核机制改革无疑会降低短期业绩压力，推动险资、企业年金、养老基金等逐步转向长期投资。"南开 大学金融学教授田利辉表示，险 ...